When endometrial cancer returns in multiple areas like the pelvis and lymph nodes, it's considered recurrent or advanced disease. Treatment options at this stage are often combined to target cancer in different locations.
Here's an overview of what treatment may look like:
- Chemotherapy – The most common approach for Show Full Answer
When endometrial cancer returns in multiple areas like the pelvis and lymph nodes, it's considered recurrent or advanced disease. Treatment options at this stage are often combined to target cancer in different locations.
Here's an overview of what treatment may look like:
- Chemotherapy – The most common approach for recurrent endometrial cancer, often using carboplatin and paclitaxel together. If those were used before, alternatives like cisplatin, docetaxel, or doxorubicin may be considered
- Radiation therapy – Can be used to target specific areas like the pelvis. Brachytherapy is an option if cancer has returned in the vaginal area
- Immunotherapy – FDA-approved options exist for recurrent endometrial cancer, helping the immune system recognize and attack cancer cells
- Hormone therapy – May be an option depending on hormone receptor status
- Targeted therapy – Guided by biomarkers like dMMR or MSI found in cancer cells
- Surgery – May be considered if cancer is confined enough to be removed Clinical trials are also worth asking about. They can provide access to newer treatments not yet widely available, which could be especially relevant given the complexity of recurrence in multiple sites.
Your oncologist will tailor a plan based on previous treatments, biomarker testing, and overall health. It's really important to have an open conversation with your care team about what combination approach makes the most sense for your specific situation.
3 days ago
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
